RDY
Dr Reddy's LaboratoriesDNYSE / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-18
Current thesis
Composite grade D from latest DB weights. Momentum 20.4 / Value 65.9
Posture
Defensive
Lead driver
Value
What changed
Value remains the lead driver in the composite, 7D delta -0.1.
What can break
Mixed signals. Wait for cleaner trend confirmation.
Momentum
20
Value
66
Sentiment
N/A
Setup hits (3d)
0 · Net Neutral
AI TargetsBase - · Bull - · Bear -
Data freshness
Prices
As of 2026-07-18
Fundamentals
As of 2026-07-17 • Vendor: Data Vendor v1
Scores
As of 2026-07-18 • Model: HYBRID_IC_RP
AI Memo
Unavailable: No memo yet
Investment thesisAs of 2026-07-18
Investment thesis
As of 2026-07-18
Supporting evidence
What
Grade D · Defensive
Confidence Medium · Net Neutral
Target $14.04
Why
Momentum20 · Δ7d -7.1
Value66 · Δ7d -0.1
SentimentN/A · Δ7d -
So what
Weak posture (Net Neutral). Prioritize risk control and patience.
Lead driver: Value · See fundamentals
Momentum
20
40% active weight
Current posture
7d trendSoftening
Δ7d
-7.1
Δ21d
-21.0
Value
66
60% active weight
Current posture
7d trendFlat
Δ7d
-0.1
Δ21d
+1.0
Sentiment
N/A
Coverage pending
No current score
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Why this grade
Composite grade D. Momentum 20.4 / Value 65.9
Fundamentals (TTM)As of 2026-07-17
Fundamentals (TTM)
As of 2026-07-17
Market Cap
$10.52B
Beta
0.38
Shares Out
832.67M
P/E (TTM)
18.1
P/S (TTM)
3.03
P/FCF (TTM)
31.28
Rev YoY
-16.4%
EPS YoY
-86.9%
Gross Margin
+51.1%
Op Margin
+20.9%
Net Debt
-$110.42M
Current Ratio
1.80
As of 2026-07-18 • Updated nightlySource: Internal modelMethodology